Genetic Variants of Adiponectin Receptor 2 and Their Impact on Metabolic Syndrome
Author Information
Author(s): Uli C. Broedl, Michael Lehrke, Elisabeth Fleischer-Brielmaier, Anne B. Tietz, Jutta M. Nagel, Burkhard Göke, Peter Lohse, Klaus G. Parhofer
Primary Institution: Klinikum Grosshadern, University of Munich
Hypothesis
Do genetic variations in AdipoR1 and AdipoR2 contribute to insulin resistance, dyslipidemia, and inflammation?
Conclusion
This study identifies a link between genetic variants of the adiponectin receptor genes and increased adiponectin levels, as well as decreased triglyceride and VLDL levels.
Supporting Evidence
- Three AdipoR2 variants were identified in perfect linkage disequilibrium.
- The identified haplotype was associated with higher plasma adiponectin levels.
- Fasting triglyceride and VLDL levels were significantly lower in subjects with the AdipoR2 SNP cluster.
Takeaway
Scientists found that certain genes related to a hormone called adiponectin can affect fat and sugar levels in the body, which is important for people with metabolic syndrome.
Methodology
The study sequenced all seven coding exons of AdipoR1 and AdipoR2 in 20 unrelated German subjects with metabolic syndrome and tested genetic variants for association with glucose, lipid, and inflammatory parameters.
Potential Biases
Potential selection bias due to the specific characteristics of the recruited subjects.
Limitations
The small sample size may limit the generalizability of the findings.
Participant Demographics
20 unrelated German individuals with metabolic syndrome, defined as abdominal overweight and insulin resistance.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website